From: Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Type | Factors | Function |
---|---|---|
Writers | METTL3 | Catalyzes m6A modification [52] |
 | METTL14 | Stabilizes the structure of MTC and recognizes target RNAs [68] |
 | WTAP | Contributes to the localization of METTL3-METTL14 heterodimer to the nuclear speckle [49, 70] |
 | VIRMA | Recruits the MTC to the special RNA site and interacts with polyadenylation cleavage factors CPSF5 and CPSF6 [51] |
 | BM15/15B | Recruits METTL3-METTL14 heterodimer to target transcripts [53] |
 | ZC3H13 | Bridges WTAP to the mRNA-binding factor Nito [55] |
 | ZCCHC4 | |
 | METTL16 | Catalyzes m6A modification in U6-snRNA and participates in pre-RNA splicing [56, 57] |
 | METTL5 | |
Erasers | FTO | |
 | ALKBH5 | |
 | ALKBH3 | |
Readers | YTHDC1 | Impacts mRNA splicing and nuclear export [37] |
 | YTHDC2 | Promotes RNA decay and translation [38] |
 | YTHDF1 | Enhances the translational rates of its mRNA targets [35] |
 | YTHDF2 | Induces mRNA degradation [36] |
 | YTHDF3 | Promotes mRNA translation (YTHDF1) and decay (YTHDF2) [39] |
 | IGF2BP1/2/3 | Promotes mRNA stability and translation [41] |
 | HNRNPA2B1/C/G | Regulates primary miRNA processing, mRNA structure and alternative splicing [44, 45] |
 | eIF3 | Promotes mRNA translation [42] |